Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Return on Sales (2016)

Historic Return on Sales for Tenax Therapeutics (TENX) over the last 7 years, with Q1 2016 value amounting to 5161.37%.

  • Tenax Therapeutics' Return on Sales changed N/A to 5161.37% in Q1 2016 from the same period last year, while for Mar 2016 it was 5161.37%, marking a year-over-year change of. This contributed to the annual value of 765.35% for FY2024, which is 4414300.0% up from last year.
  • As of Q1 2016, Tenax Therapeutics' Return on Sales stood at 5161.37%.
  • In the past 5 years, Tenax Therapeutics' Return on Sales ranged from a high of 5161.37% in Q4 2015 and a low of 70.83% during Q2 2013
  • In the last 5 years, Tenax Therapeutics' Return on Sales had a median value of 13.24% in 2012 and averaged 929.02%.
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 1642100bps in 2012, then plummeted by -2993100bps in 2013.
  • Quarter analysis of 5 years shows Tenax Therapeutics' Return on Sales stood at 3.01% in 2012, then tumbled by -2018bps to 63.77% in 2013, then dropped by -11bps to 70.83% in 2014, then skyrocketed by 7387bps to 5161.37% in 2015, then changed by 0bps to 5161.37% in 2016.
  • Its Return on Sales stands at 5161.37% for Q1 2016, versus 5161.37% for Q4 2015 and 70.83% for Q1 2014.